Pacific Pharmaceuticals   Report issue

For profit Phase 3 Phase 4
Founded: Lahore Pakistan (1990)
Status: Acquired by Procept (1998)

Organization Overview

First Clinical Trial
2005
NCT00682760
First Marketed Drug
1997
timolol (blocadren)
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

PACIFIC PHARMA

Active Ingredients

Marketed Drugs (1)

timolol (blocadren) (1997)

Drugs in Phase 4 Trials (5)

bismuth (1 trial)

metronidazole (flagyl) (1 trial)

pantoprazole (protonix) (1 trial)

ramipril (altace) (1 trial)

tetracycline (tetrex) (1 trial)

Drugs in Phase 3 Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Blepharospasm (Phase 3)

Essential Hypertension (Phase 4)

Helicobacter Infections (Phase 4)

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6